112 related articles for article (PubMed ID: 4070103)
1. Cervical cancer screening. Who needs a Pap test? How often?
Benedet JL; Murphy KJ
Postgrad Med; 1985 Dec; 78(8):69-71, 74-6, 78-9. PubMed ID: 4070103
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the cervix in a pregnant woman with negative Pap smears and colposcopic examination.
Bakri YN; Akhtar M; al-Amri A
Acta Obstet Gynecol Scand; 1990; 69(7-8):657-8. PubMed ID: 2094152
[TBL] [Abstract][Full Text] [Related]
3. Present standards for cervical cancer screening.
O'Meara AT
Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
[TBL] [Abstract][Full Text] [Related]
4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
6. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
7. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
8. The Pap smear revisited. Controversies and recent developments.
Zuna RE
Postgrad Med; 1984 Nov; 76(6):36-40, 42-3, 46. PubMed ID: 6494079
[TBL] [Abstract][Full Text] [Related]
9. Workup of the abnormal Pap test.
Bristow RE; Montz FJ
Clin Cornerstone; 2000; 3(1):12-24. PubMed ID: 11061064
[TBL] [Abstract][Full Text] [Related]
10. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
11. Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix.
Benoit AG; Krepart GV; Lotocki RJ
Am J Obstet Gynecol; 1984 Mar; 148(5):690-4. PubMed ID: 6702935
[TBL] [Abstract][Full Text] [Related]
12. Invasive squamous cell carcinoma of the cervix after recent negative cytologic test results--a distinct subgroup?
Peters RK; Thomas D; Skultin G; Henderson BE
Am J Obstet Gynecol; 1988 Apr; 158(4):926-35. PubMed ID: 3364503
[TBL] [Abstract][Full Text] [Related]
13. Winning the Pap smear case.
Campbell JB
Diagn Cytopathol; 1999 Oct; 21(4):238-9. PubMed ID: 10495315
[No Abstract] [Full Text] [Related]
14. [The role of colposcopy in evaluation of the cervix for unexpectedly positive pap smears].
Jesień-Sokołowska U; Madej JG
Przegl Lek; 1999; 56(1):17-9. PubMed ID: 10375918
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the abnormal Pap smear.
Homesley HD
Am Fam Physician; 1977 Sep; 16(3):190-4. PubMed ID: 900003
[No Abstract] [Full Text] [Related]
16. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
[TBL] [Abstract][Full Text] [Related]
17. The current status of the Papanicolaou smear.
Shingleton HM; Patrick RL; Johnston WW; Smith RA
CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
[TBL] [Abstract][Full Text] [Related]
18. The "atypical" Papanicolaou smear.
Jones WB; Saigo PE
CA Cancer J Clin; 1986; 36(4):237-42. PubMed ID: 3089544
[TBL] [Abstract][Full Text] [Related]
19. Adolescents with abnormal cervical cytology.
Schydlower M; Greeenberg H; Patterson PH
Clin Pediatr (Phila); 1981 Nov; 20(11):723-6. PubMed ID: 7297012
[TBL] [Abstract][Full Text] [Related]
20. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
